2024-12-13

From YouTube to Drug Discovery: Our Journey on the "Business of Biotech" Podcast

Publication
3

In this episode, Bioptic CEO Andrey Doronichev shares how his team went from building consumer tech to tackling the hardest problems in biotech—using AI, ultra-fast virtual screening, and a software-first mindset.

I went on the Business of Biotech podcast to tell the story of Bioptic — how a bunch of software nerds ended up building a next-gen drug discovery company.

We talk about:

  • How we use generative AI and ultra-fast screening to find new drugs
  • The awkward marriage of tech and biotech (spoiler: it's not always smooth)
  • Why access to data is the real bottleneck
  • And what’s coming next as we go deeper into solving drug discovery’s hardest problems

It’s honest. It's practical. And if you’re working at the messy edge of science and software, I think you’ll relate.

🎧 Full episode here:
https://www.youtube.com/watch?v=4mZxkA7_Cc8&ab_channel=LifeScienceConnect

– Andrey Doronichev

Get in touch

Whether you’re a researcher, potential partner, or just curious about what we’re building, drop us a message. Explore how we can push the boundaries of science and discovery.